Recap: Alector Q4 Earnings
$ALEC
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Alector (NASDAQ:ALEC) reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Alector beat estimated earnings by 36.0%, reporting an EPS of $-0.49 versus an estimate of $-0.77.
Revenue was up $750 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.13 which was followed by a 7.000000000000001% drop in the share price the next day.
Here's a look at Alector's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.66 | -0.81 | -0.75 | -0.46 |
| EPS Actual | -0.53 | 0.02 | -0.55 | -0.63 |
| Revenue Estimate | 9.97M | 3.63M | 7.96M | 30.16M |
| Revenue Actual | 9.11M | 56.21M | 16.55M | 14.44M |
To track all earnings releases for Alector visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.